{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:31:24Z","timestamp":1770287484750,"version":"3.49.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2023-02256"],"award-info":[{"award-number":["2023-02256"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007949","name":"Reumatikerf\u00f6rbundet","doi-asserted-by":"publisher","award":["R-993724"],"award-info":[{"award-number":["R-993724"]}],"id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016670","name":"Region \u00d6sterg\u00f6tland","doi-asserted-by":"publisher","award":["R\u00d6-981263"],"award-info":[{"award-number":["R\u00d6-981263"]}],"id":[{"id":"10.13039\/100016670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007857","name":"Stiftelsen Konung Gustaf V:s 80-\u00e5rsfond","doi-asserted-by":"publisher","award":["FAI-2022-0877"],"award-info":[{"award-number":["FAI-2022-0877"]}],"id":[{"id":"10.13039\/501100007857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017239","name":"Ingrid Asps Stiftelser","doi-asserted-by":"publisher","award":["HMV-2021-00121"],"award-info":[{"award-number":["HMV-2021-00121"]}],"id":[{"id":"10.13039\/501100017239","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006129","name":"Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse","doi-asserted-by":"publisher","award":["2022"],"award-info":[{"award-number":["2022"]}],"id":[{"id":"10.13039\/501100006129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>C-reactive protein (CRP) is an important pattern recognition molecule of innate immunity. Autoantibodies targeting CRP are common in patients with systemic lupus erythematosus (SLE) and the levels correlate with disease activity. The purpose of this study was to investigate binding sites of IgG autoantibodies on the full linear sequence of CRP and identify potential associations with clinical variables in well-characterized SLE patients; a secondary aim was to investigate the effect of an epitope-based synthesized peptide motif on neutrophil functions. The levels of anti-CRP and SLE-associated antibodies were assessed, and a microarray-based linear epitope mapping was performed to detect binding sites on the full CRP monomer. We observed that anti-CRP antibodies bind to a variety of linear epitopes with a higher prevalence in SLE compared to healthy blood donors. Eleven unique epitopes were identified, of which five were found exclusively in SLE. Furthermore, we show that patients with anticardiolipin IgG and\/or anti-\u03b22GPI IgG antibodies have a higher number of positive CRP epitopes, and some CRP autoantibody-specificities associate with antiphospholipid antibodies, disease activity, and classical complement activation. In addition, one identified motif was selected, synthesized, and used for studying neutrophil function. This peptide showed modulatory capacity on neutrophil oxidative burst and chemotaxis, but not on neutrophil extracellular trap formation. Our results implicate a wide variation of anti-CRP autoantibody binding motifs of the linear structure of CRP in SLE patients. Some epitopes have the potential to modify innate host responses of relevance to the pathogenesis of SLE.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1578372","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T05:29:30Z","timestamp":1747286970000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Mapping autoantibody targets of full-length C-reactive protein in systemic lupus erythematosus: importance for neutrophil function and classical complement activation"],"prefix":"10.3389","volume":"16","author":[{"given":"Jesper","family":"Karlsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Wirestam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Du\u00e0n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suhana","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Appelgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Enocsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Wetter\u00f6","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Sj\u00f6wall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"117592","DOI":"10.1016\/j.cca.2023.117592","article-title":"The pentraxin family in autoimmune disease","volume":"551","author":"Li","year":"2023","journal-title":"Clin Chim Acta"},{"key":"B2","doi-asserted-by":"publisher","first-page":"115878","DOI":"10.1016\/j.biopha.2023.115878","article-title":"Complement-pentraxins synergy: Navigating the immune battlefield and beyond","volume":"169","author":"Ma","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201601326r","article-title":"It\u2019s time to redefine inflammation","volume":"31","author":"Antonelli","year":"2017","journal-title":"FASEB J"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(24)00398-2","article-title":"Systemic lupus erythematosus","volume":"403","author":"Hoi","year":"2024","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cca.2006.12.002","article-title":"Pathogenic implications for autoantibodies against C-reactive protein and other acute phase proteins","volume":"378","author":"Sj\u00f6wall","year":"2007","journal-title":"Clin Chim Acta"},{"key":"B6","doi-asserted-by":"publisher","first-page":"R188","DOI":"10.1186\/ar2880","article-title":"Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis","volume":"11","author":"Sj\u00f6wall","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"B7","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s13075-015-0879-8","article-title":"Prognostic value of anti-CRP antibodies in lupus nephritis in long-term follow-up","volume":"17","author":"Pesickova","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1159\/000530928","article-title":"The role of anti-mCRP autoantibodies in lupus nephritis","volume":"9","author":"Yuan","year":"2023","journal-title":"Kidney Dis (Basel)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.2002.0608","article-title":"Autoantibodies to C-reactive protein is a common finding in SLE, but not in primary Sjogren\u2019s syndrome, rheumatoid arthritis or inflammatory bowel disease","volume":"19","author":"Sj\u00f6wall","year":"2002","journal-title":"J Autoimmun"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2012.01.009","article-title":"High prevalence of autoantibodies to C-reactive protein in patients with chronic hepatitis C infection: association with liver fibrosis and portal inflammation","volume":"73","author":"Sj\u00f6wall","year":"2012","journal-title":"Hum Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/imj.12501","article-title":"Pathogenic role of antibodies against monomeric C-reactive protein in tubulointerstitial nephritis and uveitis syndrome","volume":"44","author":"Jakuszko","year":"2014","journal-title":"Intern Med J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2013.764992","article-title":"C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis","volume":"46","author":"Sj\u00f6wall","year":"2013","journal-title":"Autoimmunity"},{"key":"B13","doi-asserted-by":"publisher","first-page":"103073","DOI":"10.1016\/j.jaut.2023.103073","article-title":"Extracellular vesicles opsonized by monomeric C-reactive protein (CRP) are accessible as autoantigens in patients with systemic lupus erythematosus and associate with autoantibodies against CRP","volume":"139","author":"Karlsson","year":"2023","journal-title":"J Autoimmun"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.622326","article-title":"C-reactive protein levels in systemic lupus erythematosus are modulated by the interferon gene signature and CRP gene polymorphism rs1205","volume":"11","author":"Enocsson","year":"2021","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"110281","DOI":"10.1016\/j.clim.2024.110281","article-title":"A tale of two functions: C-reactive protein complement-ary structures and their role in rheumatoid arthritis","volume":"265","author":"Ciurtin","year":"2024","journal-title":"Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00754","article-title":"Role of C-reactive protein at sites of inflammation and infection","volume":"9","author":"Sproston","year":"2018","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01750","article-title":"Regulation of the complement system by pentraxins","volume":"10","author":"Haapasalo","year":"2019","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10245837","article-title":"The complex role of C-reactive protein in systemic lupus erythematosus","volume":"10","author":"Enocsson","year":"2021","journal-title":"J Clin Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/cvr\/cvs237","article-title":"Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction","volume":"96","author":"Habersberger","year":"2012","journal-title":"Cardiovasc Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1161\/01.cir.95.1.97","article-title":"C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction","volume":"95","author":"Lagrand","year":"1997","journal-title":"Circulation"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1161\/01.atv.18.9.1386","article-title":"C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries","volume":"18","author":"Torzewski","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.108.190611","article-title":"Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques","volume":"105","author":"Eisenhardt","year":"2009","journal-title":"Circ Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvy181","article-title":"Matrix sieving-enforced retrograde transcytosis regulates tissue accumulation of C-reactive protein","volume":"115","author":"Li","year":"2019","journal-title":"Cardiovasc Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13075-022-02831-9","article-title":"Associations of C-reactive protein isoforms with systemic lupus erythematosus phenotypes and disease activity","volume":"24","author":"Karlsson","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"B25","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s12013-022-01089-x","article-title":"Regulation of conformational changes in C-reactive protein alters its bioactivity","volume":"80","author":"Ullah","year":"2022","journal-title":"Cell Biochem Biophys"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2016070735","article-title":"Autoantibodies against C-reactive protein influence complement activation and clinical course in lupus nephritis","volume":"28","author":"Li","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1181561","article-title":"Combination of anti-C1qA08 and anti-mCRP a.a.35\u201347 antibodies is associated with renal prognosis of patients with lupus nephritis","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"key":"B28","article-title":"Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome","volume":"33","author":"Figueredo","year":"2006","journal-title":"J Rheumatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2011.00070","article-title":"CRP\/anti-CRP antibodies assembly on the surfaces of cell remnants switches their phagocytic clearance toward inflammation","volume":"2","author":"Janko","year":"2011","journal-title":"Front Immunol"},{"key":"B30","article-title":"Neutrophil lysosomal degradation of human CRP: CRP-derived peptides modulate neutrophil function","volume":"73","author":"Shephard","year":"1988","journal-title":"Clin Exp Immunol"},{"key":"B31","first-page":"79","article-title":"C-reactive protein (CRP) peptides inactivate enolase in human neutrophils leading to depletion of intracellular ATP and inhibition of superoxide generation","volume":"76","author":"Shephard","year":"1992","journal-title":"Immunology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.145.5.1469","article-title":"Peptides generated from C-reactive protein by a neutrophil membrane protease. Amino acid sequence and effects of peptides on neutrophil oxidative metabolism and chemotaxis","volume":"145","author":"Shephard","year":"1990","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11585","article-title":"Epidemiology and damage accrual of systemic lupus erythematosus in central Sweden: A single-center population-based cohort study over 14 years from \u00d6sterg\u00f6tland county","volume":"5","author":"Arkema","year":"2023","journal-title":"ACR Open Rheumatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheumatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheumatol"},{"key":"B36","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq376","article-title":"The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients","volume":"50","author":"Yee","year":"2011","journal-title":"Rheumatol (Oxford)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390303","article-title":"The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for systemic lupus erythematosus","volume":"39","author":"Gladman","year":"1996","journal-title":"Arthritis Rheumatol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"102340","DOI":"10.1016\/j.jaut.2019.102340","article-title":"Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus","volume":"106","author":"Enocsson","year":"2020","journal-title":"J Autoimmun"},{"key":"B40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0022-1759(84)90432-0","article-title":"Simplified assays of hemolytic activity of the classical and alternative complement pathways","volume":"72","author":"Nilsson","year":"1984","journal-title":"J Immunol Methods"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010043","article-title":"Neutrophil extracellular traps (NETs) in the cerebrospinal fluid samples from children and adults with central nervous system infections","volume":"9","author":"Appelgren","year":"2019","journal-title":"Cells"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.10.003","article-title":"A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients","volume":"14","author":"Yaniv","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B44","doi-asserted-by":"publisher","first-page":"110873","DOI":"10.1016\/j.celrep.2022.110873","article-title":"Serum autoantibodyome reveals that healthy individuals share common autoantibodies","volume":"39","author":"Shome","year":"2022","journal-title":"Cell Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1455673","article-title":"Screening for autoimmune diseases in apparently healthy antinuclear antibody positive individuals","volume":"11","author":"Andraos","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.145.11.3869","article-title":"Identification of a polypeptide sequence that mediates nuclear localization of the acute phase protein C-reactive protein","volume":"145","author":"Du Clos","year":"1990","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.147.7.2248","article-title":"Monoclonal antibodies to the calcium-binding region peptide of human C-reactive protein alter its conformation","volume":"147","author":"Swanson","year":"1991","journal-title":"J Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.4049\/jimmunol.166.6.3998","article-title":"Topology and structure of the C1q-binding site on C-reactive protein","volume":"166","author":"Agrawal","year":"2001","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.6.3217","article-title":"A C-reactive protein mutant that does not bind to phosphocholine and pneumococcal C-polysaccharide","volume":"169","author":"Agrawal","year":"2002","journal-title":"J Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M504782200","article-title":"Analysis of binding sites in human C-reactive protein for FcgammaRI, FcgammaRIIA, and C1q by site-directed mutagenesis","volume":"280","author":"Bang","year":"2005","journal-title":"J Biol Chem"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m115.695023","article-title":"An intrinsically disordered motif mediates diverse actions of monomeric C-reactive protein","volume":"291","author":"Li","year":"2016","journal-title":"J Biol Chem"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02126","article-title":"How C-reactive protein structural isoforms with distinctive bioactivities affect disease progression","volume":"11","author":"Rajab","year":"2020","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2019.10.013","article-title":"Monomeric C-reactive protein regulates fibronectin mediated monocyte adhesion","volume":"117","author":"Ullah","year":"2020","journal-title":"Mol Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"110353","DOI":"10.1016\/j.clim.2024.110353","article-title":"The anti-mCRP(199-206) antibodies aggravate tubulointerstitial lesions in lupus nephritis","volume":"268","author":"Yuan","year":"2024","journal-title":"Clin Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2019.09.014","article-title":"B-cell epitopes: Discontinuity and conformational analysis","volume":"114","author":"Ferdous","year":"2019","journal-title":"Mol Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2012.03.030","article-title":"An analysis of B-cell epitope discontinuity","volume":"51","author":"Sivalingam","year":"2012","journal-title":"Mol Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2005.10.010","article-title":"C-reactive protein products generated by neutrophil elastase promote neutrophil apoptosis","volume":"37","author":"Kakuta","year":"2006","journal-title":"Arch Med Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1128\/cvi.00155-06","article-title":"Antibodies against C-reactive protein cross-react with 60-kilodalton heat shock proteins","volume":"14","author":"Udvarnoki","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2019.06.001","article-title":"Low production of reactive oxygen species drives systemic lupus erythematosus","volume":"25","author":"Urbonaviciute","year":"2019","journal-title":"Trends Mol Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12915-024-02093-8","article-title":"A conformational change of C-reactive protein drives neutrophil extracellular trap formation in inflammation","volume":"23","author":"Karasu","year":"2025","journal-title":"BMC Biol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1578372\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T05:29:33Z","timestamp":1747286973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1578372\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":60,"alternative-id":["10.3389\/fimmu.2025.1578372"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1578372","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"article-number":"1578372"}}